| Literature DB >> 28678810 |
Hongling Wang1,2, Xiaoyang Tang3, Yi-Cheng Su4, Jiabei Chen1,2, Jianbo Yan1,2.
Abstract
Vibrio parahaemolyticus is recognized as major cause of foodborne illness of global public health concern. This study collected 107 strains of V. parahaemolyticus during active surveillance of diarrheal diseases in hospitals in Zhoushan during 2013 to 2014 and investigated their serotypes, virulence genes (tdh, trh, and orf8), antimicrobial resistance, and genotypes. The dominant serotypes of the 107 clinical strains were O3:K6, O4:K8, and O4:KUT with 87.9% and 3.7% of the strains carrying the virulence genes tdh and trh, respectively. Molecular typing by pulsed-field gel electrophoresis indicated divergence among the clinical strains. Most isolates were sensitive to the common antimicrobial agents used against the Vibrio species except ampicillin. We conclude that continuous surveillance of V. parahaemolyticus in diarrhea patients is a public health priority and is useful for conducting risk assessment of foodborne illnesses caused by V. parahaemolyticus.Entities:
Mesh:
Year: 2017 PMID: 28678810 PMCID: PMC5498046 DOI: 10.1371/journal.pone.0180335
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Oligonucleotide primers used for polymerase chain reactions [16].
| Target genes | Primers (Probes) | Sequence (5’-3’) | Amplicon |
|---|---|---|---|
| F-tl | 450 | ||
| R-tl | |||
| P-tl952 | |||
| F- | 229 | ||
| R- | |||
| P- | |||
| F- | 207 | ||
| R- | |||
| P- | |||
| F-O3MM824 | 369 | ||
| R-O3MM1192 | |||
| P-ORFORF8-853 |
Fig 1Serological analysis of clinical V. parahaemolyticus isolates from patients in Zhoushan in 2013 (n = 41) and 2014 (n = 66).
Serotypes and virulence factors of 107 clinical V. parahaemolyticus isolated from patients in Zhoushan between 2013 and 2014.
| O serogroups | Serovars | No. of isolate (s) | Virulence index | |||
|---|---|---|---|---|---|---|
| Kanagawa phenomenon | ||||||
| O1 | O1:KUT | 1 | + | + | − | + |
| 1 | + | − | − | + | ||
| 4 | − | − | − | − | ||
| O2 | O2:KUT | 1 | − | − | − | + |
| O3 | O3:K6 | 18 | + | − | + | + |
| 4 | + | − | + | − | ||
| 8 | + | − | − | + | ||
| 1 | + | − | − | − | ||
| O3:KUT | 2 | + | − | − | + | |
| 3 | − | − | − | − | ||
| O4 | O4:K8 | 2 | + | − | + | + |
| 32 | + | − | − | + | ||
| 2 | + | − | − | − | ||
| O4:KUT | 2 | + | − | + | + | |
| 1 | + | − | + | − | ||
| 10 | + | − | − | + | ||
| 7 | + | − | − | − | ||
| O5 | O5:KUT | 2 | − | − | − | − |
| O10 | O10:KUT | 2 | + | + | − | + |
| 1 | − | − | − | − | ||
| O11 | O11:KUT | 1 | − | + | − | − |
| O12 | O12:KUT | 1 | + | − | + | + |
| 1 | − | − | − | − | ||
a Associated with pandemic isolates.
Fig 2Pulsed-field gel electrophoresis of NotI-digested genomic DNA of selected clinical and foodborne V. parahaemolyticus isolates obtained in Zhoushan.
Strain identification number, isolation date, and seromarkers.
Antimicrobial susceptibility testing of 107 V. parahaemolyticus strains.
| Antimicrobial agent | Susceptible (%) | Intermediate (%) | Resistant (%) |
|---|---|---|---|
| Gentamicin | 94.4 | 4.7 | 0.9 |
| Amikacin | 96.2 | 3.8 | 0.0 |
| Meropenem | 100.0 | 0.0 | 0.0 |
| Imipenem | 100.0 | 0.0 | 0.0 |
| Cefoxitin | 100.0 | 0.0 | 0.0 |
| Cefepime | 99.1 | 0.9 | 0.0 |
| Ceftazidime | 100.0 | 0.0 | 0.0 |
| Cefazolin | 45.3 | 54.7 | 0.0 |
| Trimethoprim/sulfamethoxazole | 100.0 | 0.0 | 0.0 |
| Chloramphenicol | 100.0 | 0.0 | 0.0 |
| Amoxicillin/clavulanic acid | 100.0 | 0.0 | 0.0 |
| Ampicillin | 0.0 | 14.2 | 85.8 |
| Ciprofloxacin | 100.0 | 0.0 | 0.0 |
| Levofloxacin | 100.0 | 0.0 | 0.0 |
| Tetracycline | 100.0 | 0.0 | 0.0 |